WO2003077723A3 - Methods and devices for detection and therapy of atheromatous plaque - Google Patents

Methods and devices for detection and therapy of atheromatous plaque Download PDF

Info

Publication number
WO2003077723A3
WO2003077723A3 PCT/US2002/038852 US0238852W WO03077723A3 WO 2003077723 A3 WO2003077723 A3 WO 2003077723A3 US 0238852 W US0238852 W US 0238852W WO 03077723 A3 WO03077723 A3 WO 03077723A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapy
detection
devices
methods
fluorescent
Prior art date
Application number
PCT/US2002/038852
Other languages
French (fr)
Other versions
WO2003077723A2 (en
Inventor
Alan Fischman
Michael R Hamblin
Ahmed Tawakol
Tayyaba Hasan
James Muller
Rox Anderson
David R Elmaleh
Farhad Daghighian
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Priority to JP2003575782A priority Critical patent/JP2005538751A/en
Priority to EP02795747A priority patent/EP1575414A4/en
Priority to AU2002360488A priority patent/AU2002360488A1/en
Priority to CA002478248A priority patent/CA2478248A1/en
Publication of WO2003077723A2 publication Critical patent/WO2003077723A2/en
Publication of WO2003077723A3 publication Critical patent/WO2003077723A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • A61B18/245—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/42—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4258—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00057—Light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00079—Radioactivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00904—Automatic detection of target tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A61N2005/0602—Apparatus for use inside the body for treatment of blood vessels

Abstract

The present invention relates to devices for detection and therapy of active atheromatous plaque and/or thin-capped fibro-atheroma ('vulnerable plaque'), using selectively targeted fluorescent, radiolabeled, or fluorescent and radiolabeled compositions. The present invention further relates to methods and devices for detection and therapy of active atheromatous plaques and/or vulnerable plaques, using selectively targeted compositions, optionally comprising fluorescent and/or radiolabeled compositions.
PCT/US2002/038852 2002-03-15 2002-12-03 Methods and devices for detection and therapy of atheromatous plaque WO2003077723A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2003575782A JP2005538751A (en) 2002-03-15 2002-12-03 Methods and apparatus for detection and treatment of atherosclerotic plaque
EP02795747A EP1575414A4 (en) 2002-03-15 2002-12-03 Methods and devices for detection and therapy of atheromatous plaque
AU2002360488A AU2002360488A1 (en) 2002-03-15 2002-12-03 Methods and devices for detection and therapy of atheromatous plaque
CA002478248A CA2478248A1 (en) 2002-03-15 2002-12-03 Methods and devices for detection and therapy of atheromatous plaque

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US36567302P 2002-03-15 2002-03-15
US60/365,673 2002-03-15
US10,163,744 2002-06-04
US10/163,744 US20030103995A1 (en) 2001-06-04 2002-06-04 Detection and therapy of vulnerable plaque with photodynamic compounds
US10/215,958 US20030082105A1 (en) 2001-06-04 2002-08-09 Methods and devices for detection and therapy of atheromatous plaque
US10/215,600 US7809428B2 (en) 2001-06-04 2002-08-09 Devices for detection and therapy of atheromatous plaque
US10/216,026 2002-08-09
US10/215,600 2002-08-09
US10/215,958 2002-08-09
US10/216,026 US20060073100A1 (en) 2001-06-04 2002-08-09 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions

Publications (2)

Publication Number Publication Date
WO2003077723A2 WO2003077723A2 (en) 2003-09-25
WO2003077723A3 true WO2003077723A3 (en) 2007-07-12

Family

ID=27388922

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2002/018472 WO2003003975A2 (en) 2001-06-04 2002-06-04 Detection and therapy of vulnerable plaque with photodynamic compounds
PCT/US2002/038852 WO2003077723A2 (en) 2002-03-15 2002-12-03 Methods and devices for detection and therapy of atheromatous plaque

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2002/018472 WO2003003975A2 (en) 2001-06-04 2002-06-04 Detection and therapy of vulnerable plaque with photodynamic compounds

Country Status (8)

Country Link
US (5) US20030103995A1 (en)
EP (2) EP1401479B1 (en)
JP (2) JP2005502618A (en)
AT (1) ATE359806T1 (en)
AU (2) AU2002327180A1 (en)
CA (2) CA2449828A1 (en)
DE (1) DE60219627T2 (en)
WO (2) WO2003003975A2 (en)

Families Citing this family (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7426409B2 (en) * 1999-06-25 2008-09-16 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
JP4241038B2 (en) 2000-10-30 2009-03-18 ザ ジェネラル ホスピタル コーポレーション Optical method and system for tissue analysis
US9295391B1 (en) * 2000-11-10 2016-03-29 The General Hospital Corporation Spectrally encoded miniature endoscopic imaging probe
US20030064025A1 (en) * 2001-04-05 2003-04-03 Xiaoming Yang Imaging systems for in vivo protocols
US7865231B2 (en) 2001-05-01 2011-01-04 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
DE60219627T2 (en) * 2001-06-04 2008-02-07 The General Hospital Corp., Boston IDENTIFICATION AND THERAPY OF SENSITIVE PLAQUE WITH PHOTODYNAMIC COMPOUNDS
US20030013986A1 (en) * 2001-07-12 2003-01-16 Vahid Saadat Device for sensing temperature profile of a hollow body organ
US7355716B2 (en) 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
AU2003239375A1 (en) * 2002-05-07 2003-11-11 Volcano Therapeutics, Inc. Systems and methods for detecting vulnerable plaque
EP1513853A2 (en) * 2002-05-24 2005-03-16 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
EA200401565A1 (en) * 2002-05-24 2005-04-28 Неофарм, Инк. METHOD FOR OBTAINING CARDIOLYPINE OR ANALOGUE OF CARDIOLIPINE (OPTIONS), METHOD FOR OBTAINING LIPOSOME AND COMPOSITION OF CARDIOLIPINE FOR TREATING DISEASES (OPTIONS)
US7326238B1 (en) 2002-09-30 2008-02-05 Abbott Cardiovascular Systems Inc. Method and apparatus for treating vulnerable plaque
US7008411B1 (en) * 2002-09-30 2006-03-07 Advanced Cardiovascular Systems, Inc. Method and apparatus for treating vulnerable plaque
US20060265043A1 (en) * 2002-09-30 2006-11-23 Evgenia Mandrusov Method and apparatus for treating vulnerable plaque
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
WO2004088361A2 (en) 2003-03-31 2004-10-14 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US8054468B2 (en) 2003-01-24 2011-11-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US7153299B1 (en) 2003-02-24 2006-12-26 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7297154B2 (en) * 2003-02-24 2007-11-20 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7515626B2 (en) * 2003-05-29 2009-04-07 Novera Optics, Inc. Light source capable of lasing that is wavelength locked by an injected light signal
KR101386971B1 (en) 2003-06-06 2014-04-18 더 제너럴 하스피탈 코포레이션 Process and apparatus for a wavelength tunning source
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
US20050049228A1 (en) * 2003-09-02 2005-03-03 Ceramoptec Industries Inc. Antimicrobial photodynamic therapy compound and method of use
US20050053590A1 (en) * 2003-09-05 2005-03-10 The Texas A&M University System Endothelium-targeting nanoparticle for reversing endothelial dysfunction
US7733497B2 (en) 2003-10-27 2010-06-08 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
DE10354496B4 (en) * 2003-11-21 2011-03-31 Siemens Ag Medical examination and / or treatment system
US7258697B1 (en) 2003-12-22 2007-08-21 Advanced Cardiovascular Systems, Inc. Stent with anchors to prevent vulnerable plaque rupture during deployment
US7242480B2 (en) * 2004-05-14 2007-07-10 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
US7474408B2 (en) * 2004-05-14 2009-01-06 Medeikon Corporation Low coherence interferometry utilizing phase
US20050254059A1 (en) * 2004-05-14 2005-11-17 Alphonse Gerard A Low coherence interferometric system for optical metrology
AU2004320269B2 (en) 2004-05-29 2011-07-21 The General Hospital Corporation Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (OCT) imaging
WO2006014392A1 (en) * 2004-07-02 2006-02-09 The General Hospital Corporation Endoscopic imaging probe comprising dual clad fibre
US20130040043A1 (en) * 2004-08-04 2013-02-14 Marian L. Larson Method of coating medical devices including application of peptide linker coating
US8081316B2 (en) 2004-08-06 2011-12-20 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US8208995B2 (en) 2004-08-24 2012-06-26 The General Hospital Corporation Method and apparatus for imaging of vessel segments
WO2006024014A2 (en) 2004-08-24 2006-03-02 The General Hospital Corporation Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample
US20090104119A1 (en) * 2004-08-25 2009-04-23 Majoros Istvan J Dendrimer Based Compositions And Methods Of Using The Same
US7365859B2 (en) 2004-09-10 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
EP2329759B1 (en) 2004-09-29 2014-03-12 The General Hospital Corporation System and method for optical coherence imaging
WO2006050058A2 (en) * 2004-10-28 2006-05-11 The General Hospital Corporation Methods of detection and therapy of inflamed tissues using immune modulation
US20080193376A1 (en) * 2004-10-28 2008-08-14 The General Hospital Corporation Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation
JP2008521516A (en) 2004-11-29 2008-06-26 ザ ジェネラル ホスピタル コーポレイション Configuration, apparatus, endoscope, catheter, and method for performing optical image generation by simultaneously illuminating and detecting multiple points on a sample
WO2006089118A2 (en) * 2005-02-17 2006-08-24 Light Sciences Oncology, Inc. Photoreactive system and methods for prophylactic treatment of atherosclerosis
US7560227B2 (en) * 2005-02-28 2009-07-14 University Of Massachusetts Biomarkers of vulnerable atherosclerotic plaques and methods of use
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
EP2325803A1 (en) 2005-04-28 2011-05-25 The General Hospital Corporation Evaluating optical coherence tomography information for an anatomical structure
WO2006128016A2 (en) * 2005-05-25 2006-11-30 Prescient Medical, Inc. Methods and systems for treating vulnerable plaques
US8355776B2 (en) 2005-05-27 2013-01-15 Board Of Regents, The University Of Texas System Hemoglobin contrast in magneto-motive optical doppler tomography, optical coherence tomography, and ultrasound imaging methods and apparatus
WO2007117572A2 (en) * 2005-05-27 2007-10-18 Board Of Regents, University Of Texas System Optical coherence tomographic detection of cells and killing of the same
KR20080023292A (en) * 2005-05-27 2008-03-13 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 Optical coherence tomographic detection of cells and compositions
US9060689B2 (en) 2005-06-01 2015-06-23 The General Hospital Corporation Apparatus, method and system for performing phase-resolved optical frequency domain imaging
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
ES2354287T3 (en) 2005-08-09 2011-03-11 The General Hospital Corporation APPARATUS AND METHOD FOR PERFORMING A DEMODULATION IN QUADRATURE BY POLARIZATION IN OPTICAL COHERENCE TOMOGRAPHY.
JP2007091673A (en) * 2005-09-29 2007-04-12 Toshiba Corp Blood circulation promoter, blood-circulating apparatus and blood circulation-promoting medical system
US20070073364A1 (en) * 2005-09-29 2007-03-29 Siemens Aktiengesellschaft Combined OCT catheter device and method for combined optical coherence tomography (OCT) diagnosis and photodynamic therapy (PDT)
CN101365375B (en) 2005-09-29 2013-09-11 通用医疗公司 Method and apparatus for optical imaging via spectral encoding
US7889348B2 (en) 2005-10-14 2011-02-15 The General Hospital Corporation Arrangements and methods for facilitating photoluminescence imaging
EP1971848B1 (en) 2006-01-10 2019-12-04 The General Hospital Corporation Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US7842465B2 (en) * 2006-01-17 2010-11-30 Palo Alto Research Center Incorporated Immunocytostaining methods for enhanced dye ratio discrimination in rare event detection
US8145018B2 (en) 2006-01-19 2012-03-27 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
PL1973466T3 (en) 2006-01-19 2021-07-05 The General Hospital Corporation Ballon imaging catheter
JP5524487B2 (en) 2006-02-01 2014-06-18 ザ ジェネラル ホスピタル コーポレイション A method and system for emitting electromagnetic radiation to at least a portion of a sample using a conformal laser treatment procedure.
WO2007149603A2 (en) 2006-02-01 2007-12-27 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
WO2007149601A2 (en) * 2006-02-01 2007-12-27 The General Hospital Corporation Apparatus for controlling at least one of at least two sections of at least one fiber
JP5519152B2 (en) 2006-02-08 2014-06-11 ザ ジェネラル ホスピタル コーポレイション Device for acquiring information about anatomical samples using optical microscopy
JP2007223966A (en) * 2006-02-24 2007-09-06 Pentax Corp Cell surface- or tissue surface-staining agent composition and staining method using the same
EP1987318B1 (en) 2006-02-24 2015-08-12 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
US8435276B2 (en) * 2006-02-27 2013-05-07 Thomas Perez Method and apparatus for the combined application of light therapy, optic diagnosis, and fluid to tissue
WO2007103721A2 (en) * 2006-03-01 2007-09-13 The General Hospital Corporation System and method for providing cell specific laser therapy of atherosclerotic plaques by targeting light absorbers in macrophages
JP5135324B2 (en) 2006-04-05 2013-02-06 ザ ジェネラル ホスピタル コーポレイション Method, arrangement and system for polarization sensitive optical frequency domain imaging of samples
US8187189B2 (en) 2006-04-28 2012-05-29 The Invention Science Fund I, Llc Imaging via blood vessels
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2007130465A2 (en) * 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
EP2517616A3 (en) 2006-05-10 2013-03-06 The General Hospital Corporation Processes, arrangements and systems for providing frequency domain imaging of a sample
US20080275432A1 (en) * 2006-05-11 2008-11-06 Ceramoptec Industries, Inc. Photodynamic foam composition and sclerosis treatment
WO2007133964A2 (en) 2006-05-12 2007-11-22 The General Hospital Corporation Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images
US7572625B2 (en) * 2006-05-18 2009-08-11 Boston Scientific Scimed, Inc. Medical devices coated with drug carrier macromolecules
US7488930B2 (en) * 2006-06-02 2009-02-10 Medeikon Corporation Multi-channel low coherence interferometer
JP2010502646A (en) * 2006-08-29 2010-01-28 バイオストリーム セラピューティクス インコーポレーティッド Radioactive imaging moiety that images peptidase-expressing tissues and organs in combination with peptidase binding moieties
US8882674B2 (en) * 2006-09-28 2014-11-11 Research Foundation Of The City University Of New York System and method for in vivo imaging of blood vessel walls to detect microcalcifications
WO2008049118A2 (en) 2006-10-19 2008-04-24 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample and effecting such portion(s)
US8108030B2 (en) 2006-10-20 2012-01-31 Board Of Regents, The University Of Texas System Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles
WO2008067079A2 (en) * 2006-10-20 2008-06-05 Cardiospectra, Inc. Method and apparatus to identify vulnerable plaques with thermal wave imaging of heated nanoparticles
US8155730B2 (en) * 2006-10-24 2012-04-10 The Research Foundation Of State University Of New York Composition, method, system, and kit for optical electrophysiology
US8000774B2 (en) * 2007-01-03 2011-08-16 Infraredx, Inc. Method and system for intra luminal thrombus detection
WO2008086376A2 (en) * 2007-01-08 2008-07-17 Light Sciences Oncology, Inc. Therapeutic devices for the treatment of varicosity
US7911621B2 (en) * 2007-01-19 2011-03-22 The General Hospital Corporation Apparatus and method for controlling ranging depth in optical frequency domain imaging
US7949019B2 (en) 2007-01-19 2011-05-24 The General Hospital Wavelength tuning source based on a rotatable reflector
EP2602651A3 (en) 2007-03-23 2014-08-27 The General Hospital Corporation Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US10534129B2 (en) 2007-03-30 2020-01-14 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
WO2008122056A2 (en) * 2007-04-02 2008-10-09 Case Western Reserve University Medical apparatus and method associated therewith
EP3192369B1 (en) 2007-04-12 2018-12-12 The General Hospital Corporation Biomimetic vascular network
WO2008131082A1 (en) 2007-04-17 2008-10-30 The General Hospital Corporation Apparatus and methods for measuring vibrations using spectrally-encoded endoscopy techniques
US8115919B2 (en) 2007-05-04 2012-02-14 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
WO2009009786A2 (en) 2007-07-12 2009-01-15 Board Of Regents, The University Of Texas System Magneto-motive ultrasound detection of magnetic nanoparticles
JP5917803B2 (en) 2007-07-31 2016-05-18 ザ ジェネラル ホスピタル コーポレイション System and method for emitting a beam scanning pattern for fast Doppler optical frequency domain imaging
IL185128A0 (en) * 2007-08-08 2008-01-06 Kerber Tom Irradiating strip catheter
US7682089B2 (en) * 2007-08-15 2010-03-23 Rohlen Brooks H System and method for positioning a probe
US8480662B2 (en) * 2007-08-22 2013-07-09 Cardiac Pacemakers, Inc. Systems and devices for photoablation
EP2191254B1 (en) 2007-08-31 2017-07-19 The General Hospital Corporation System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith
US20090131801A1 (en) * 2007-10-12 2009-05-21 The General Hospital Corporation Systems and processes for optical imaging of luminal anatomic structures
WO2009059034A1 (en) 2007-10-30 2009-05-07 The General Hospital Corporation System and method for cladding mode detection
GB0803076D0 (en) * 2008-02-20 2008-03-26 Univ Ghent Mucosal Membrane Receptor and uses thereof
US7898656B2 (en) 2008-04-30 2011-03-01 The General Hospital Corporation Apparatus and method for cross axis parallel spectroscopy
EP2274572A4 (en) 2008-05-07 2013-08-28 Gen Hospital Corp System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
CA2891990C (en) 2008-05-20 2022-07-26 Ralph Sebastian Dacosta Device and method for fluorescence-based imaging and monitoring
WO2009155536A2 (en) 2008-06-20 2009-12-23 The General Hospital Corporation Fused fiber optic coupler arrangement and method for use thereof
WO2010009136A2 (en) 2008-07-14 2010-01-21 The General Hospital Corporation Apparatus and methods for color endoscopy
US9204925B2 (en) * 2008-08-14 2015-12-08 The Cleveland Clinic Foundation Apparatus and method for treating a neuromuscular defect
KR20100030195A (en) * 2008-09-09 2010-03-18 서울대학교산학협력단 Fluorescent silica nanoparticle with radioactive tag and the detecting method of pet and fluorescent dual imaging using thereof
FR2935924B1 (en) * 2008-09-18 2010-11-12 Sidel Participations DEVICE AND METHOD FOR MEASURING THE WALL TEMPERATURE OF A CONTAINER BLANK
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
WO2010062557A2 (en) * 2008-10-27 2010-06-03 University Of Virginia Patent Foundation Multimodal imaging of atherosclerotic plaque targeted to lox-1
WO2010054321A2 (en) 2008-11-07 2010-05-14 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
JP5731394B2 (en) 2008-12-10 2015-06-10 ザ ジェネラル ホスピタル コーポレイション System, apparatus and method for extending imaging depth range of optical coherence tomography through optical subsampling
JP5355074B2 (en) * 2008-12-26 2013-11-27 キヤノン株式会社 3D shape data processing apparatus, 3D shape data processing method and program
US9615748B2 (en) 2009-01-20 2017-04-11 The General Hospital Corporation Endoscopic biopsy apparatus, system and method
WO2010085775A2 (en) 2009-01-26 2010-07-29 The General Hospital Corporation System, method and computer-accessible medium for providing wide-field superresolution microscopy
CN102308444B (en) 2009-02-04 2014-06-18 通用医疗公司 Apparatus and method for utilization of a high-speed optical wavelength tuning source
US9351642B2 (en) 2009-03-12 2016-05-31 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)
US20100312312A1 (en) * 2009-06-09 2010-12-09 Gary Wayne Jones Method for selective photodynamic therapy and light source for implementation thereof
BR112012001042A2 (en) 2009-07-14 2016-11-22 Gen Hospital Corp fluid flow measurement equipment and method within anatomical structure.
HU230008B1 (en) * 2009-09-01 2015-05-28 Szegedi Tudományegyetem Improved tonometric device for examination of respiratory insufficiency and regional perfusion failure of the body
WO2011059609A2 (en) 2009-10-13 2011-05-19 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
WO2011059586A2 (en) 2009-10-30 2011-05-19 The Regents Of The University Of Michigan Multifunctional small molecules
US9211283B2 (en) * 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
US20120022380A1 (en) * 2010-01-19 2012-01-26 Chernomorsky Ary S Methods and apparatus for assesment and treatment of body cavities
ES2831223T3 (en) 2010-03-05 2021-06-07 Massachusetts Gen Hospital Apparatus for providing electromagnetic radiation to a sample
US20130289520A1 (en) * 2010-04-23 2013-10-31 Children's Hospital Boston Targeted and light-activated cytosolic drug delivery
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
US9795301B2 (en) 2010-05-25 2017-10-24 The General Hospital Corporation Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
EP2575591A4 (en) 2010-06-03 2017-09-13 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
US9510758B2 (en) 2010-10-27 2016-12-06 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US20120265062A1 (en) * 2011-04-13 2012-10-18 St. Jude Medical, Inc. Optical coherence tomography catheter for elastographic property mapping of lumens utilizing micropalpation
WO2012149175A1 (en) 2011-04-29 2012-11-01 The General Hospital Corporation Means for determining depth-resolved physical and/or optical properties of scattering media
US9492113B2 (en) 2011-07-15 2016-11-15 Boston Scientific Scimed, Inc. Systems and methods for monitoring organ activity
WO2013013049A1 (en) 2011-07-19 2013-01-24 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US10241028B2 (en) 2011-08-25 2019-03-26 The General Hospital Corporation Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
WO2013052848A1 (en) * 2011-10-07 2013-04-11 Boston Scientific Scimed, Inc. Methods for detection and thermal treatment of lower urinary tract conditions
WO2013052852A1 (en) 2011-10-07 2013-04-11 Boston Scientific Scimed, Inc. Methods and systems for detection and thermal treatment of lower urinary tract conditions
EP2769491A4 (en) 2011-10-18 2015-07-22 Gen Hospital Corp Apparatus and methods for producing and/or providing recirculating optical delay(s)
US9402911B2 (en) 2011-12-08 2016-08-02 The Regents Of The University Of Michigan Multifunctional small molecules
WO2013148306A1 (en) 2012-03-30 2013-10-03 The General Hospital Corporation Imaging system, method and distal attachment for multidirectional field of view endoscopy
JP6398093B2 (en) * 2012-04-13 2018-10-03 ベイカー ハート アンド ダイアベーツ インスティテュート Detection of atherosclerotic plaque
US10512691B2 (en) * 2012-04-23 2019-12-24 The Regents Of The University Of Michigan Systems and methods for targeted imaging and ablation of cardiac cells
WO2013177154A1 (en) 2012-05-21 2013-11-28 The General Hospital Corporation Apparatus, device and method for capsule microscopy
JP6227652B2 (en) 2012-08-22 2017-11-08 ザ ジェネラル ホスピタル コーポレイション System, method, and computer-accessible medium for fabricating a miniature endoscope using soft lithography
JP6654897B2 (en) 2012-08-31 2020-02-26 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ Particles, methods and uses thereof
CN103721257B (en) * 2012-10-16 2016-12-21 无锡兆真辐射技术有限公司 Phytochrome catalytic decomposition hydrogen peroxide medicine series
US9968403B2 (en) * 2012-10-16 2018-05-15 Boston Scientific Scimed, Inc. Surgical laser system and laser fiber
CA2894719C (en) 2012-12-19 2019-10-22 Sloan-Kettering Institute For Cancer Research Multimodal particles, methods and uses thereof
JP6560126B2 (en) 2013-01-28 2019-08-14 ザ ジェネラル ホスピタル コーポレイション Apparatus and method for providing diffusion spectroscopy superimposed on optical frequency domain imaging
WO2014120791A1 (en) 2013-01-29 2014-08-07 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
US11179028B2 (en) 2013-02-01 2021-11-23 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
CA2900686A1 (en) * 2013-02-20 2014-08-28 Sloan-Kettering Institute For Cancer Research Wide field raman imaging apparatus and associated methods
JP6378311B2 (en) 2013-03-15 2018-08-22 ザ ジェネラル ホスピタル コーポレイション Methods and systems for characterizing objects
WO2014186353A1 (en) 2013-05-13 2014-11-20 The General Hospital Corporation Detecting self-interefering fluorescence phase and amplitude
WO2015009932A1 (en) 2013-07-19 2015-01-22 The General Hospital Corporation Imaging apparatus and method which utilizes multidirectional field of view endoscopy
EP3021735A4 (en) 2013-07-19 2017-04-19 The General Hospital Corporation Determining eye motion by imaging retina. with feedback
EP3025173B1 (en) 2013-07-26 2021-07-07 The General Hospital Corporation Apparatus with a laser arrangement utilizing optical dispersion for applications in fourier-domain optical coherence tomography
US9733460B2 (en) 2014-01-08 2017-08-15 The General Hospital Corporation Method and apparatus for microscopic imaging
WO2015116986A2 (en) 2014-01-31 2015-08-06 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
US11547300B2 (en) * 2014-01-31 2023-01-10 The General Hospital Corporation Methods of treating and imaging tumor micrometastases using photoactive immunoconjugates
US10912947B2 (en) 2014-03-04 2021-02-09 Memorial Sloan Kettering Cancer Center Systems and methods for treatment of disease via application of mechanical force by controlled rotation of nanoparticles inside cells
WO2015153982A1 (en) 2014-04-04 2015-10-08 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
DK3171765T3 (en) 2014-07-24 2021-11-01 Univ Health Network COLLECTION AND ANALYSIS OF DATA FOR DIAGNOSTIC PURPOSES
WO2016015052A1 (en) * 2014-07-25 2016-01-28 The General Hospital Corporation Apparatus, devices and methods for in vivo imaging and diagnosis
US10688202B2 (en) 2014-07-28 2020-06-23 Memorial Sloan-Kettering Cancer Center Metal(loid) chalcogen nanoparticles as universal binders for medical isotopes
US10175219B2 (en) * 2014-07-28 2019-01-08 The Board Of Trustees Of The Leland Stanford Junior University Method to sort cells on the basis of radionuclide uptake
US20160058502A1 (en) * 2014-08-27 2016-03-03 Boston Scientific Scimed, Inc. Devices for damaging nerves and related methods of use
CA2974329C (en) 2015-01-19 2018-10-02 Theralase Technologies, Inc. Metal-glycoprotein complexes and their use as chemotherapeutic compounds
US10111936B2 (en) 2015-01-19 2018-10-30 Theralase Technologies, Inc. Metal-glycoprotein complexes and photodynamic therapy of immune privileged sites with same
WO2017004301A1 (en) 2015-07-01 2017-01-05 Memorial Sloan Kettering Cancer Center Anisotropic particles, methods and uses thereof
US11094058B2 (en) * 2015-08-14 2021-08-17 Elucid Bioimaging Inc. Systems and method for computer-aided phenotyping (CAP) using radiologic images
US20220012877A1 (en) * 2015-08-14 2022-01-13 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque fissure non-invasively
US20230368365A9 (en) * 2015-08-14 2023-11-16 Elucid Bioimaging Inc. Quantitative imaging for detecting histopathologically defined plaque erosion non-invasively
US10675462B2 (en) 2015-11-04 2020-06-09 Boston Scientific Scimed, Inc. Medical device and related methods
KR101880613B1 (en) * 2017-09-29 2018-07-20 박우태 Dental mirror having lighting function
CN108956564B (en) * 2018-06-21 2020-12-29 深圳市优迈医学科技有限公司 Photosensitizer concentration detection device, system and method
US11397331B2 (en) * 2018-10-22 2022-07-26 California Institute Of Technology Color and multi-spectral image sensor based on 3D engineered material
US11239276B2 (en) 2019-10-18 2022-02-01 California Institute Of Technology CMOS color image sensors with metamaterial color splitting
CN111707664A (en) * 2020-05-19 2020-09-25 西安交通大学 Observation experiment device suitable for super hydrophobic surface
JP2023530710A (en) * 2020-06-19 2023-07-19 ザ ジェネラル ホスピタル コーポレイション Near-infrared autofluorescence imaging system and method
TWI815720B (en) * 2022-11-03 2023-09-11 財團法人金屬工業研究發展中心 Signal transmitting element

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6295680B1 (en) * 1998-07-05 2001-10-02 The Regents Of The University Of Michigan Method for detecting early atherosclerosis and vascular damage using radioactive tracers and intravascular radiation detection devices

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US618402A (en) * 1899-01-31 Flat stripping motion for carding engines
US4141347A (en) * 1976-09-21 1979-02-27 Sri International Real-time ultrasonic B-scan imaging and Doppler profile display system and method
US4512762A (en) * 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US5693043A (en) * 1985-03-22 1997-12-02 Massachusetts Institute Of Technology Catheter for laser angiosurgery
US5104392A (en) * 1985-03-22 1992-04-14 Massachusetts Institute Of Technology Laser spectro-optic imaging for diagnosis and treatment of diseased tissue
US4920143A (en) 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US4995396A (en) * 1988-12-08 1991-02-26 Olympus Optical Co., Ltd. Radioactive ray detecting endoscope
WO1990006718A1 (en) * 1988-12-21 1990-06-28 Massachusetts Institute Of Technology A method for laser induced fluorescence of tissue
US5046501A (en) * 1989-01-18 1991-09-10 Wayne State University Atherosclerotic identification
US5008546A (en) * 1990-06-18 1991-04-16 The Regents Of The University Of California Intraoperative beta probe and method of using the same
US5197470A (en) * 1990-07-16 1993-03-30 Eastman Kodak Company Near infrared diagnostic method and instrument
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
US5169395A (en) * 1991-04-26 1992-12-08 Pdt Cardiovascular, Inc. Laser delivery system
JP3154742B2 (en) * 1991-04-30 2001-04-09 日本石油化学株式会社 Remedy for mammalian atherosclerosis
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
AU3922193A (en) * 1992-03-23 1993-10-21 Georgetown University Liposome encapsulated taxol and a method of using the same
ATE194916T1 (en) * 1992-05-06 2000-08-15 Immunomedics Inc INTRAOPERATIVE, INTRAVASCULAR AND ENDOSCOPIC DETERMINATION AND TREATMENT OF INJURIES AND TUMORS
JPH05330716A (en) * 1992-05-25 1993-12-14 Eastman Kodak Japan Kk Discharged paper accumulating device
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5776966A (en) * 1992-05-27 1998-07-07 University Of British Columbia Selective cell inactivation in blood
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
ES2160600T3 (en) * 1992-09-21 2001-11-16 Quadra Logic Tech Inc TRANSCUTANEOUS ACTIVATION IN VIVO OF PHOTOSENSIBLE AGENTS IN THE BLOOD.
US5409710A (en) 1993-04-20 1995-04-25 Endocon, Inc. Foam cell drug delivery
WO1995000605A1 (en) 1993-06-18 1995-01-05 Aktsionernoe Obschestvo Otkrytogo Tipa 'yaroslavnefteorgsintez' Process for obtaining benzenes and a catalyst
US5422362A (en) * 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis
US5798349A (en) * 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
ATE207932T1 (en) * 1994-07-22 2001-11-15 Univ Duke PORPHYRIN AND HUMAN SERUM ALBUMINE COMPLEXES WITH THE ABILITY TO BIND OXYGEN AND THEIR THERAPEUTIC USES
US5639600A (en) * 1994-08-05 1997-06-17 The Regents Of The University Of California Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement
US5568532A (en) * 1994-08-12 1996-10-22 Southeastern Universities Research Association, Inc. Examination system utilizing ionizing radiation and a flexible, miniature radiation detector probe
US5891108A (en) * 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US6008211A (en) * 1995-07-27 1999-12-28 Pdt Pharmaceuticals, Inc. Photoactivatable compounds comprising benzochlorin and furocoumarin
US5760674A (en) * 1995-11-28 1998-06-02 International Business Machines Corporation Fusible links with improved interconnect structure
US5952329A (en) * 1996-01-23 1999-09-14 The General Hospital Corporation Benzophenothiazine and benzoporphyrin dye combination photodynamic therapy of tumors
US5811814A (en) * 1996-02-12 1998-09-22 Cordis Corporation Radiation measuring catheter apparatus and method
US20030138411A1 (en) * 1996-05-02 2003-07-24 Glaxo Wellcome Inc. Gene expression in monocytes and macrophages
US6076009A (en) * 1997-05-05 2000-06-13 The University Of Michigan Solid state beta-sensitive surgical probe
US5932879A (en) * 1996-05-07 1999-08-03 Regents Of The University Of Michigan Solid state beta-sensitive surgical probe
US5744805A (en) * 1996-05-07 1998-04-28 University Of Michigan Solid state beta-sensitive surgical probe
US5834503A (en) * 1996-06-14 1998-11-10 Qlt Phototherapeutics, Inc. Methods to treat arterial plaque
US5924997A (en) * 1996-07-29 1999-07-20 Campbell; Thomas Henderson Catheter and method for the thermal mapping of hot spots in vascular lesions of the human body
US5829448A (en) * 1996-10-30 1998-11-03 Photogen, Inc. Method for improved selectivity in photo-activation of molecular agents
US6286514B1 (en) * 1996-11-05 2001-09-11 Jerome Lemelson System and method for treating select tissue in a living being
US6180402B1 (en) * 1996-11-20 2001-01-30 Qlt Inc. Method for inhibiting apoptosis induced by photodynamic therapy using a cysteine or serine protease inhibitor
US5919135A (en) * 1997-02-28 1999-07-06 Lemelson; Jerome System and method for treating cellular disorders in a living being
US6238348B1 (en) * 1997-07-22 2001-05-29 Scimed Life Systems, Inc. Miniature spectrometer system and method
US5864141A (en) * 1997-07-23 1999-01-26 Southeastern Univ. Research Assn. Compact, high-resolution, gamma ray imaging for scintimammography and other medical diagostic applications
HUP0004412A3 (en) * 1997-08-14 2003-06-30 Hoffmann La Roche Use of heterocyclic vinylethers for the preparation of pharmaceutical compositions treating neurological disorders
WO1999012579A1 (en) 1997-09-08 1999-03-18 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
US6033436A (en) * 1998-02-17 2000-03-07 Md3, Inc. Expandable stent
US20020115649A1 (en) * 1998-07-06 2002-08-22 Pharmacyclics, Inc. Use of texaphyrins in macrophage-mediated disease
AU6417599A (en) * 1998-10-08 2000-04-26 University Of Kentucky Research Foundation, The Methods and apparatus for (in vivo) identification and characterization of vulnerable atherosclerotic plaques
US6211349B1 (en) * 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US6167297A (en) * 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
US6782289B1 (en) * 1999-10-08 2004-08-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for characterizing lesions in blood vessels and other body lumens
US6716410B1 (en) * 1999-10-26 2004-04-06 The Regents Of The University Of California Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
JP2003513027A (en) * 1999-10-26 2003-04-08 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア Agent and method for diagnosing, imaging and treating atherosclerosis
US6750037B2 (en) * 1999-12-27 2004-06-15 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
US7373197B2 (en) * 2000-03-03 2008-05-13 Intramedical Imaging, Llc Methods and devices to expand applications of intraoperative radiation probes
GB0121171D0 (en) * 2001-08-31 2001-10-24 Glaxosmithkline Biolog Sa Vaccine
JP4238476B2 (en) * 2000-12-08 2009-03-18 株式会社デンソー Starter with intermediate gear
US6547812B1 (en) * 2000-12-29 2003-04-15 Advanced Cardiovascular Systems, Inc. Radiation therapy using a radioactive implantable device and a radiosensitizer agent
WO2002067761A2 (en) * 2001-02-23 2002-09-06 Bristol-Myers Squibb Pharma Company Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
US6894161B2 (en) * 2001-03-27 2005-05-17 The University Of British Columbia Methods and compositions for photo-cross linking photoactive compounds to target tissue
US6764501B2 (en) * 2001-04-10 2004-07-20 Robert A. Ganz Apparatus and method for treating atherosclerotic vascular disease through light sterilization
WO2002096417A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
DE60219627T2 (en) 2001-06-04 2008-02-07 The General Hospital Corp., Boston IDENTIFICATION AND THERAPY OF SENSITIVE PLAQUE WITH PHOTODYNAMIC COMPOUNDS
US20070264194A1 (en) * 2001-08-10 2007-11-15 The Scripps Research Institute Peptides That Bind To Atherosclerotic Lesions
US20030152513A1 (en) * 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
DE10226420A1 (en) * 2002-06-13 2004-01-15 Eucro European Contract Research Gmbh & Co Kg Procedure for the treatment of atherosclerosis
WO2004110250A2 (en) * 2003-05-30 2004-12-23 Purdue Research Foundation Diagnostic method for atherosclerosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6295680B1 (en) * 1998-07-05 2001-10-02 The Regents Of The University Of Michigan Method for detecting early atherosclerosis and vascular damage using radioactive tracers and intravascular radiation detection devices

Also Published As

Publication number Publication date
WO2003003975A2 (en) 2003-01-16
CA2449828A1 (en) 2003-01-16
EP1401479B1 (en) 2007-04-18
US20060073100A1 (en) 2006-04-06
ATE359806T1 (en) 2007-05-15
EP1401479A4 (en) 2005-03-16
DE60219627D1 (en) 2007-05-31
CA2478248A1 (en) 2003-09-25
WO2003003975A3 (en) 2003-12-11
JP2005502618A (en) 2005-01-27
US7809428B2 (en) 2010-10-05
EP1401479A2 (en) 2004-03-31
AU2002360488A1 (en) 2003-09-29
US20030055307A1 (en) 2003-03-20
EP1575414A2 (en) 2005-09-21
US20030103995A1 (en) 2003-06-05
EP1575414A4 (en) 2008-02-20
JP2005538751A (en) 2005-12-22
DE60219627T2 (en) 2008-02-07
AU2002327180A1 (en) 2003-01-21
AU2002360488A8 (en) 2003-09-29
WO2003077723A2 (en) 2003-09-25
US20030082105A1 (en) 2003-05-01
US20070258906A1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
WO2003077723A3 (en) Methods and devices for detection and therapy of atheromatous plaque
AU2002254158A1 (en) Medical devices, compositions and methods for treating vulnerable plaque
WO2004006858A3 (en) Compounds, compositions, and methods employing same
AU2002257936A1 (en) Methods of well treatment
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004045516A9 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003101397A3 (en) Tetravalent dengue vaccines
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
EP1578450A4 (en) Amplification of biotin-mediated targeting
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005046578A3 (en) Isoquinolinone potassium channel inhibitors
WO2003057160A8 (en) Compositions and methods for the diagnosis and treatment of tumor
YU89503A (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
WO2004052236A3 (en) Methods and compositions for treatment of otitis media
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
WO2002092024A3 (en) Compounds and methods for inhibiting axillary malodour
MXPA03007126A (en) Parasiticidal compositions and methods of use.
EP1551388A4 (en) Compounds useful for the treatment of cancer, compositions thereof and methods therewith
IL164887A0 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AUPR582001A0 (en) Protection of blast holes
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
WO2003039484A3 (en) Novel compositions and methods for cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2478248

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003575782

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002795747

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2002795747

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)